000 | 01291nam a2200169Ia 4500 | ||
---|---|---|---|
008 | 220514s9999||||xx |||||||||||||| ||und|| | ||
020 | _a92-9036-071-2 | ||
050 | _aQV 748 .C56 1999 | ||
100 | _aBankowski, Z. (ed.)|Bruppacher, R. (ed.)|Crusius, I. (ed.)|Gallagher, J. (ed.)|Kremer, G. (ed.)|Venulet, J. (ed.) | ||
110 | _aCouncil for International Organisations of Medical Sciences (CIOMS) | ||
245 | 0 | _aReporting adverse drug reactions: Definitions of terms and criteria for their use | |
260 |
_aGeneva _bCouncil for International Organisations of Medical Sciences (CIOMS) _c1999 |
||
300 | _axxii, 146p. | ||
500 | _aPresents standard definitions of selected for adverse drug reactions and on minimum requirements for the use of the terms in international reporting, in the framework of post-marketing surveillance. The terms and definitions are accepted across cultures and among the various linguistic backgrounds in the medical and educational systems. The book begins by explaining why its development and publication were necessary before presenting the terms. The terms are defined and the circumstances under which they may be used explained, synonymous terms are also provided. | ||
650 | _aPharmaceutical Preparations|Legislation, Drug|Pharmacology | ||
942 |
_2lcc _cBK |
||
999 |
_c5464 _d5464 |